Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Medscape

Questions persist about possible varied heart failure drug efficacy by race. But perhaps less so now, at least for the investigational agent omecamtiv mecarbil, after a GALACTIC-HF subanalysis.